Showing 1 - 10 of 3,862
competition in the drug market over time are all shaped by regulation. Throughout much of the world, administrative regulation …Very few industries are as profoundly influenced by regulation as the pharmaceutical industry. All aspects of the life … and competition with generics. The nature of demand for drugs, the identity of drugs brought to market, and the nature of …
Persistent link: https://www.econbiz.de/10012980141
this paper, we take a close look at competition among the generic entrants during the first three years after patent … expiration and examine whether there is a first mover advantage. We specify a random effect nested logit model of competition … that allows for competition between the brand drug and generics, and among multiple generic drugs. The model accommodates …
Persistent link: https://www.econbiz.de/10012709667
increased competition between healthcare providers on prescription of antibiotics. We make use of a competition- inducing reform … different subcategories of antibiotics. The results indicate that increased competition had a positive and significant effect on …
Persistent link: https://www.econbiz.de/10009793592
model to study consumers’ buying behavior and firm competition in the post patent ethical drug markets. We use the estimated …
Persistent link: https://www.econbiz.de/10014036939
international pharmaceutical industry. Regulation adds complexity to the activities of a firm. This complexity is multiplied, if … industry and thereby a factor for industry concentration. High industry concentration leads to reduced competition which in … industry activities proceeds, national regulation aimed at reducing costs for pharmaceuticals can have the unintended effect of …
Persistent link: https://www.econbiz.de/10013127115
, competitive asymmetry, presuming that the competition among the companies is not equal and rivals do not consider each other at …
Persistent link: https://www.econbiz.de/10012302774
Persistent link: https://www.econbiz.de/10009625666
The lobbying literature provides evidence of firms shaping their regulatory context, consistent with corporate rent-seeking. We propose that such rent-seeking, where it exists, is unlikely to enrich shareholders at the expense of customers when firms operate in competitive product markets. We...
Persistent link: https://www.econbiz.de/10011800739
What are the trends in the global competitiveness of the Indian pharmaceutical industry? Where does this industry stand when compared to global peers on pharmaceutical value-added, productivity, research and development and trade performance? What are the new strategies that Indian...
Persistent link: https://www.econbiz.de/10014200371
Multinational companies (MNCs) from emerging markets (EMs) are new and very dynamic actors on the global scene. Starting from the late 1970s a strand of literature flourished on Third World multinationals (Lall, 1983a). More recently, the increasing expansion abroad by multinationals based in...
Persistent link: https://www.econbiz.de/10014202975